Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Recruiting
Observational Study
Fertility Preservation
Cancer Remission
Reproductive Outcomes
Reproductive Health
Oncology
Fertility Counseling
Assisted Reproductive Technology
Psychological Impact
Fertility Observatory
Patient Follow-up
Female Cancer Survivors
Fertility Preservation Techniques
Live Birth Rate
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 47
- Sex
- Any
- Study type
- Observational
- Participants needed
- 102 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity.
Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment.
However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission.
This proje…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women
* Aged between 18 and 47 years
* Diagnosed with cancer or hematological disorders requiring potentially gonadotoxic treatment
* Having undergone a medical fertility preservation consultation
* Followed at Amiens Picardie University Hospital (CHU Amiens Picardie) in the d…
Contacts